Max Reinhardt, President at Pacira BioSciences, Inc. (PCRX), sold 28,308 shares at $60.26 ($1.7M) on 2020-09-17, disclosed to the SEC on 2020-09-21.
Open-market sale of $1.7M PCRX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.75 | 22,532 | $1.3M | 79.5% |
| 2 | $60.26 | 2,888 | $174K | 10.3% |
| 3 | $60.26 | 2,888 | $174K | 10.3% |
| Total | $59.85 avg | 28,308 | $1.7M | 100% |
| Filing → |
| PCRX | SELL | 2023-06-07 | $83K | — | Filing → |
| PCRX | SELL | 2022-10-11 | $80K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $497K | — | Filing → |